Bypassing pleural aspiration for early tissue diagnosis in suspected pleural malignancy: Development and external validation of a predictive model using supervised machine learning.
{"title":"Bypassing pleural aspiration for early tissue diagnosis in suspected pleural malignancy: Development and external validation of a predictive model using supervised machine learning.","authors":"Adhnan Omar, Artemio Gonzales, Alina Ionescu","doi":"10.5339/qmj.2026.14","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>The conventional diagnostic pathway for pleural malignancy involves pleural aspiration, often followed by tissue biopsy. However, pleural aspiration has limited sensitivity, which can potentially delay a definitive diagnosis. The objective of this study was to develop and externally validate a predictive model using clinical data to identify patients who could safely bypass pleural aspiration and proceed directly to tissue biopsy.</p><p><strong>Methods: </strong>This was a retrospective cohort study of patients presenting to an acute hospital in the UK with suspected pleural malignancy between 2016 and 2025 (n = 646). A Random Forest classifier was trained on this dataset, and its performance was evaluated using an independent external validation cohort from another acute hospital in the UK (<i>n</i> = 32). Model performance was assessed using standard metrics, including accuracy, precision, recall, F1-score, and the area under the receiver operating characteristic curve (ROC-AUC).</p><p><strong>Results: </strong>The model demonstrated robust performance in the internal dataset and maintained its predictive strength during external validation (AUC: 0.86 vs. 0.83; precision 87% vs. 85%; recall 79% vs. 75%). Among the variables, computed tomography findings were the most influential predictor, as quantified by Gini importance. A simplified scoring system was subsequently derived for potential bedside clinical application.</p><p><strong>Conclusion: </strong>This externally validated model provides a valuable decision-support tool for clinicians, facilitating earlier tissue diagnosis in patients with suspected pleural malignancy. By potentially avoiding non-diagnostic aspiration, the model can streamline the diagnostic pathway and expedite patient care. Successful external validation enhances confidence in the model's generalizability and supports its potential for implementation into routine clinical practice.</p>","PeriodicalId":53667,"journal":{"name":"Qatar Medical Journal","volume":"2026 1","pages":"14"},"PeriodicalIF":0.0000,"publicationDate":"2026-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13006752/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Qatar Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5339/qmj.2026.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objective: The conventional diagnostic pathway for pleural malignancy involves pleural aspiration, often followed by tissue biopsy. However, pleural aspiration has limited sensitivity, which can potentially delay a definitive diagnosis. The objective of this study was to develop and externally validate a predictive model using clinical data to identify patients who could safely bypass pleural aspiration and proceed directly to tissue biopsy.
Methods: This was a retrospective cohort study of patients presenting to an acute hospital in the UK with suspected pleural malignancy between 2016 and 2025 (n = 646). A Random Forest classifier was trained on this dataset, and its performance was evaluated using an independent external validation cohort from another acute hospital in the UK (n = 32). Model performance was assessed using standard metrics, including accuracy, precision, recall, F1-score, and the area under the receiver operating characteristic curve (ROC-AUC).
Results: The model demonstrated robust performance in the internal dataset and maintained its predictive strength during external validation (AUC: 0.86 vs. 0.83; precision 87% vs. 85%; recall 79% vs. 75%). Among the variables, computed tomography findings were the most influential predictor, as quantified by Gini importance. A simplified scoring system was subsequently derived for potential bedside clinical application.
Conclusion: This externally validated model provides a valuable decision-support tool for clinicians, facilitating earlier tissue diagnosis in patients with suspected pleural malignancy. By potentially avoiding non-diagnostic aspiration, the model can streamline the diagnostic pathway and expedite patient care. Successful external validation enhances confidence in the model's generalizability and supports its potential for implementation into routine clinical practice.
背景和目的:胸膜恶性肿瘤的常规诊断途径包括胸膜穿刺,通常随后进行组织活检。然而,胸膜穿刺的敏感性有限,这可能会延迟最终诊断。本研究的目的是利用临床数据开发并外部验证一种预测模型,以确定可以安全地绕过胸膜穿刺并直接进行组织活检的患者。方法:这是一项回顾性队列研究,纳入了2016年至2025年间在英国一家急性医院就诊的疑似胸膜恶性肿瘤患者(n = 646)。在此数据集上训练随机森林分类器,并使用来自英国另一家急性医院的独立外部验证队列(n = 32)对其性能进行评估。使用标准指标评估模型性能,包括准确性、精密度、召回率、f1评分和受试者工作特征曲线下面积(ROC-AUC)。结果:该模型在内部数据集中表现出稳健的性能,并在外部验证中保持其预测强度(AUC: 0.86 vs. 0.83;精度87% vs. 85%;召回率79% vs. 75%)。在变量中,计算机断层扫描结果是最具影响力的预测因子,通过基尼重要性量化。一个简化的评分系统随后衍生出潜在的床边临床应用。结论:该外部验证模型为临床医生提供了有价值的决策支持工具,有助于对疑似胸膜恶性肿瘤患者进行早期组织诊断。通过潜在地避免非诊断性误吸,该模型可以简化诊断途径并加快患者护理。成功的外部验证增强了对模型的普遍性的信心,并支持其在常规临床实践中实施的潜力。